Mirum Pharmaceuticals, Inc. MIRM
96.97 USD +9.94 (+11.42%)
At closeNov 4, 2026, 4:01 PM EST
96.97 0.00 0.00%
After hours · Nov 4, 4:01 PM ET
83.13 Day range 97.26
63.23 52-week range 130.00
- YTD
- +22.76%
- 1 year
- +36.64%
Financial health
Altman Z-Score
-0.45 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -168×
FY 2018 5y median -7.4× FY 2025
P/S 7.6×
FY 2018 5y median 7.6× FY 2025
P/B 12.6×
FY 2018 5y median 4.9× FY 2025
P/FCF 72.3×
FY 2018 5y median -3.2× FY 2025
EV/EBITDA 232×
FY 2018 5y median -7.0× FY 2025
EV/Sales 7.6×
FY 2018 5y median 7.6× FY 2025
FCF Yield 1.4%
FY 2018 5y median -7.5% FY 2025
Profitability
Gross Margin 80.7%
FY 2018 5y median 80.7% FY 2025
Operating Margin -4.2%
FY 2018 5y median -58.6% FY 2025
Net Margin -4.5%
FY 2018 5y median -87.7% FY 2025
ROE -7.4%
FY 2018 5y median -65.7% FY 2025
ROIC -3.5%
FY 2018 5y median -19.5% FY 2025
ROA -2.8%
FY 2018 5y median -25.3% FY 2025
Growth (YoY)
Revenue 54.7%
FY 2018 FY 2025
Operating Income 74.7%
FY 2018 FY 2025
EPS (diluted) 74.6%
FY 2018 FY 2025
Free Cash Flow 488.0%
FY 2018 FY 2025
Financial Health
Current Ratio 2.7×
FY 2018 5y median 3.1× FY 2025
Quick Ratio 2.6×
FY 2018 5y median 2.9× FY 2025
Debt / Equity 1.0×
FY 2018 5y median 1.0× FY 2025
Net Debt / EBITDA 1.3×
FY 2018 5y median 0.2× FY 2025
Interest Coverage -1.5×
FY 2018 5y median -7.2× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31